Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Cash & Current Investments: 2018-2025

Historic Cash & Current Investments for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $43.5 million.

  • Evolus' Cash & Current Investments fell 48.82% to $43.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $260.1 million, marking a year-over-year decrease of 23.16%. This contributed to the annual value of $87.0 million for FY2024, which is 38.37% up from last year.
  • According to the latest figures from Q3 2025, Evolus' Cash & Current Investments is $43.5 million, which was down 29.50% from $61.7 million recorded in Q2 2025.
  • In the past 5 years, Evolus' Cash & Current Investments ranged from a high of $146.3 million in Q4 2021 and a low of $22.2 million during Q1 2021.
  • Its 3-year average for Cash & Current Investments is $64.6 million, with a median of $62.8 million in 2023.
  • Per our database at Business Quant, Evolus' Cash & Current Investments crashed by 77.75% in 2021 and then soared by 381.13% in 2022.
  • Evolus' Cash & Current Investments (Quarterly) stood at $146.3 million in 2021, then tumbled by 63.13% to $53.9 million in 2022, then grew by 16.53% to $62.8 million in 2023, then soared by 38.37% to $87.0 million in 2024, then slumped by 48.82% to $43.5 million in 2025.
  • Its Cash & Current Investments stands at $43.5 million for Q3 2025, versus $61.7 million for Q2 2025 and $67.9 million for Q1 2025.